Sethuraman Natarajan
CIK 0001873394
President, Research & Develop.
Filings
19
Latest May 4, 2026
Issuers covered
1
Showing
19 of 19
Page 1
Track record
21 of 21 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 21 | 52% | +5.8% | +5.7% | +58.3% | -15.7% |
| 90 days | 20 | 75% | +14.7% | +22.9% | +44.2% | -43.2% |
| 180 days | 20 | 85% | +30.1% | +39.5% | +60.9% | -33.2% |
| 365 days | 20 | 100% | +51.7% | +58.2% | +65.8% | +12.6% |
Issuers
Companies where Sethuraman Natarajan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 19 | May 4, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|